Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels

Pancreatic ductal adenocarcinoma (PDAC) responds poorly to checkpoint blockade, such as anti-CTLA-4 and anti-PD-1. Galectin-9, a β-galactoside-binding lectin, promotes immune suppression through T-cell inhibition, and programming of tolerogenic macrophages. Of all cancers tested, PDAC showed the hig...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncogene
Auteurs principaux: Seifert, Adrian M., Reiche, Charlotte, Heiduk, Max, Tannert, Anna, Meinecke, Ann-Christin, Baier, Stephanie, von Renesse, Janusz, Kahlert, Christoph, Distler, Marius, Welsch, Thilo, Reissfelder, Christoph, Aust, Daniela E., Miller, George, Weitz, Jürgen, Seifert, Lena
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7142017/
https://ncbi.nlm.nih.gov/pubmed/32055023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1186-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires